August is National Immunization Awareness Month (NIAM)

This annual observance highlights the efforts of health care professionals to protect patients of all ages against vaccine-preventable diseases through on-time vaccination. The Centers for Disease Control and Prevention has many resources and toolkits for health care professionals: https://www.cdc.gov/vaccines/events/niam/index.html

If you have vaccination questions, our team has over 20 years of experience in handling vaccine call centers, contact us: 877-477-0977 or https://medcommunications.com/contact-us/

#ivax2protect #NIAM

Is your Pharmacovigilance Department inspection-ready?

Is your pharmacovigilance (PV) department ready for an inspection by the FDA, EMA, or other regulatory bodies? With over 20 years of experience, our PV experts can help you identify potential areas of concern and suggest a plan for improvement. Let us help you perform your audit to verify you are ready for inspection!

PV – Audit-ready

If you want more information on our pharmacovigilance services, contact us: 877-477-0977 or https://medcommunications.com/contact-us/

#fda #ema #pharmacovigilance #inspections #pv

Take a look at our Promotional Review Services

We know that promotional review is a time-consuming process. We offer three levels of involvement in your promotional review committee (PRC): reference validation, medical QA and fact check, and full medical review. You choose how to let our experienced team help your PRC!

75%

If you want to learn more about how we can carry some of the promotional review load, contact us: 877-477-0977 or https://medcommunications.com/contact-us/

#promoreview #PRC

AMCP Format for Formulary Dossiers Series – What’s in an Unapproved Product Use Dossier?

In an Unapproved Use Dossier, the information is similar to those sections in an Unapproved Product Dossier. There is some information included about the Approved Product, but this dossier should NOT provide value propositions or conclusions/characterizations about safety and effectiveness of the new use. There might be less economic information, as it might be similar to the Approved product and only anticipated changes in costs need to be explained.

AMCP Format v4.1 Posts_AMCP_Unapproved_Use_Sections

If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/

Now Hiring

We have three new positions at our Memphis headquarters:

Medical Information Assistant https://recruiting.paylocity.com/Recruiting/Jobs/Details/293630

Medical Information Specialist https://recruiting.paylocity.com/Recruiting/Jobs/Details/296183

Pharmacovigilance Specialist https://recruiting.paylocity.com/Recruiting/Jobs/Details/301789

 

To apply: https://recruiting.paylocity.com/recruiting/jobs/List/3532/Med-Communications-Inc

#nowhiring

No Project is too Big or too Small for our Call Center Team

At Med Communications, our services are flexible to meet your needs now and in the future. Our staff has the clinical expertise to address medical information questions quickly and accurately while possessing the sensitivity to help your customers and are available to take your calls 24 hours a day/ 7 days a week/ 365 days a year. Our multilingual staff is accessible via phone, email, webchat, video conferencing, and mobile devices. Language capabilities include English, French, German, Portuguese, and Spanish.

If you need any level of medical information call center, whether full-service or just services to add on to your normal call center offerings (such as after-hours or holidays), contact us: 877-477-0977 or https://medcommunications.com/contact-us/

#medicalinformation #therightpartner #therightresource

Celebrating 22 Years! Thank You, Clients!

Med Communications is celebrating its 22nd year of business this month, and we want to let our clients, big and small, to know how much we appreciate their business!

We look forward to continuing to pursue our mission: Med Communications is passionate about delivering high-quality global medical affairs, pharmacovigilance, and commercial solutions to pharmaceutical, biotech, and device companies. We do this by building lasting partnerships with our clients while providing employees with a meaningful professional experience.

If you need full-service medical information call center, pharmacovigilance, or medical writing, contact us: 877-477-0977 or https://medcommunications.com/contact-us/

#medicalinformation #medicalwriting # pharmacovigilance

AMCP Format for Formulary Dossiers Series – What’s in an Approved Product Dossier? Section Six

The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we have been covering it section by section in the past weeks.

The contents of Section 6 are pretty self-explanatory. It contains all of the references for the dossier, any economic models discussed in Section 5, a copy of the approved Prescribing Information, any patient information, and a Material Safety Data Sheet (MSDS).

AMCP Format v4.1 Posts_AMCP_Approved_Section 6

If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/

#AMCP #dossierwriting #managedcare

AMCP Format for Formulary Dossiers Series – What’s in an Approved Product Dossier? Section Five

The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.

Section 5 can provide additional types of evidence and studies that did not fit into Section 3.0B, such as clinical practice guidelines, HTAs and systematic review, compendia, modeling, and pharmacoeconomic studies. Many dossiers only have information in a section or two of Section 5, but it’s available if there are other types of evidence to provide to health care decision makers.

AMCP Format v4.1 Posts_AMCP_Approved_Section 5

Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/

#AMCP #dossierwriting #managedcare

AMCP Format for Formulary Dossiers Series – What’s in an Approved Product Dossier? Section Four

The contents of the Approved Product Dossier do not change in the new AMCP Format for Formulary Dossiers, but there is so much to talk about with this type of dossier, so we will be covering it section by section in the coming weeks.

Section 4 provides guidance for different types of models used to show the economic value of a product. Depending on the models available, this section could be really short or longer given the level of detail required to evaluate the models.

AMCP Format v4.1 Posts_AMCP_Approved_Section Four

Follow our page to keep up with all of the sections of the new AMCP Format for Formulary Submissions. If you need any assistance with creating or updating your dossier, let us know: 877-477-0977 or https://medcommunications.com/contact-us/

#AMCP #dossierwriting #managedcare